CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
述评：是时候探索缺失的环节了：COVID 感染与癌细胞之间的交互对话；关于一线免疫疗法对不可预测的“Omicron 幽灵”的纵向疗效的悬而未决问题，以及 CAR-T 细胞疗法指向更佳临床结局的启示
英文原题：Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable "Omicron ghosts" and insights from CAR-T cell therapy pointing toward better clinical outcomes.
查看英文原题
Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable "Omicron ghosts" and insights from CAR-T cell therapy pointing toward better clinical outcomes.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
摘要
这条来源本身就没有摘要（PubMed 未提供），不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。
论文信息
- 作者
- Seghatchian J
- 单位
- International Consultancy in Innovative Manufacturing and Quality/Safety of Blood-Derived Bioproducts, London, England, UK. Electronic address: jseghatchian@btopenworld.com.Italy
- 文献类型
- 社论
- 期刊
- Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2022 Aug
- 原文标识
- PubMed 35717374 · DOI 10.1016/j.transci.2022.103490
在 PubMed 查看 → 出版商原文（DOI） 全文 PDF（PMC）· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →